Shing Chuan Hooi

Hooi Shing Chuan

  • Professor, Department of Physiology
Academic Qualifications
  • PhD, Harvard University, USA
  • MBBS, National University of Singapore, Singapore
Research Interest(s)
  • CEBP-alpha
  • Gene-regulation
  • Education
Recent Publications
  • 1. Zhou J, Tang Y, Xie ZJ, Lu JN, Deng JH, Huang XW, Hooi SC, He M, Lu GD. 2017 Apr. AKT activation was not essential for hepatocellular carcinoma cell survival under glucose deprivation. Anticancer Drugs. 28(4):427-435. doi: 10.1097/CAD.0000000000000475. |Tochhawng L, Deng S, Pugalenthi G, Kumar AP, Lim KH, Yang H, Hooi SC, Goh YC, Maciver SK, Pervaiz S et al. 2016 Aug. Gelsolin-Cu/ZnSOD interaction alters intracellular reactive oxygen species levels to promote cancer cell invasion. Oncotarget. 7(33):52832-52848. doi:10.18632/oncotarget.10451.
  • 2. Qiu GH, Xie X, Deng L, Hooi SC. 2015 Nov. Tumor Suppressor DLEC1 can Stimulate the Proliferation of Cancer Cells When AP-2ɑ2 is Down-Regulated in HCT116. Hepat Mon. 15(11):e29829. doi: 10.5812/hepatmon.29829.
  • 3. Ler SY, Leung CH, Khin LW, Lu GD, Salto-Tellez M, Hartman M, Iau PT, Yap CT, Hooi SC. 2015 Nov. HDAC1 and HDAC2 independently predict mortality in hepatocellular carcinoma by a competing risk regression model in a Southeast Asian population. Oncol Rep. 34(5):2238-50. doi: 10.3892/or.2015.4263.
  • 4. Lu GD, Ang YH, Zhou J, Tamilarasi J, Yan B, Lim YC, Srivastava S, Salto-Tellez M, Hui KM, Shen HM, Nguyen LN, Tan BC, Silver DL, Hooi SC. 2015 Mar. CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation-induced cell death in hepatocellular carcinoma. Hepatology. 61(3):965-78. doi: 10.1002/hep.27593.